· 个股论点

NBIS短期受稀释压制,但基本面强劲,当前股价被低估。

涉及标的:

中文翻译

价值27亿美元的自动交易机制(ATM)股份稀释将对$NBIS股价造成短期压力。 从根本上看,他们每年90亿美元年度经常性收入(ARR)的规模及其利润率,理应使其市值达到1000亿美元。 我认为,即使考虑到稀释因素,股价也应远高于当前水平(可转换票据(Convertible Notes)发行价在138美元以上),而这还是在其疯狂的ARR增长和与$META的交易之前。

英文原文

The $2.7B worth of ATM shares for dilution will put short term pressure on $NBIS stock price. Fundamentally doing $9B ARR a year with their margins should bring them to a $100B marketcap anyway. I'd argue stock price should be way up above these levels even factoring in dilution. (convertible notes were at $138+), and this was before their ridiculous ARR growth and $META deal.

在 X 上查看原推 ↗